David Isla‐Ortiz

414 total citations
25 papers, 162 citations indexed

About

David Isla‐Ortiz is a scholar working on Oncology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, David Isla‐Ortiz has authored 25 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Obstetrics and Gynecology and 8 papers in Reproductive Medicine. Recurrent topics in David Isla‐Ortiz's work include Uterine Myomas and Treatments (6 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Ovarian cancer diagnosis and treatment (5 papers). David Isla‐Ortiz is often cited by papers focused on Uterine Myomas and Treatments (6 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Ovarian cancer diagnosis and treatment (5 papers). David Isla‐Ortiz collaborates with scholars based in Mexico, United States and Colombia. David Isla‐Ortiz's co-authors include Luis A. Herrera, Lucely Cetina, Denisse Castro-Eguiluz, David Cantú de León, José Luis Aguilar-Ponce, Abraham Pedroza‐Torres, Carlos Pérez‐Plasencia, Alejandro Mohar, Rosalío Ramos‐Payán and Ángel Herrera‐Gómez and has published in prestigious journals such as International Journal of Molecular Sciences, Medicine and The Oncologist.

In The Last Decade

David Isla‐Ortiz

19 papers receiving 161 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Isla‐Ortiz Mexico 7 65 60 49 37 28 25 162
Ovidiu Coza Romania 7 140 2.2× 101 1.7× 31 0.6× 52 1.4× 30 1.1× 15 250
Nadia Raban France 7 43 0.7× 22 0.4× 62 1.3× 20 0.5× 6 0.2× 17 145
Zhongqiu Lin China 8 47 0.7× 52 0.9× 32 0.7× 46 1.2× 60 2.1× 25 182
Nisreen Anfinan Saudi Arabia 9 58 0.9× 32 0.5× 49 1.0× 25 0.7× 98 3.5× 26 234
M.I. Castillejo Spain 8 63 1.0× 79 1.3× 99 2.0× 19 0.5× 17 0.6× 12 197
Lisa Richters Germany 6 44 0.7× 37 0.6× 42 0.9× 6 0.2× 26 0.9× 13 129
Isabell Ge Germany 6 28 0.4× 33 0.6× 47 1.0× 16 0.4× 5 0.2× 11 127
Alexandra Meuter United States 4 134 2.1× 43 0.7× 79 1.6× 10 0.3× 9 0.3× 5 182
Sanya Anand United States 4 60 0.9× 134 2.2× 232 4.7× 19 0.5× 20 0.7× 5 365
Marie Ange Mouret‐Reynier France 2 53 0.8× 23 0.4× 117 2.4× 8 0.2× 9 0.3× 3 149

Countries citing papers authored by David Isla‐Ortiz

Since Specialization
Citations

This map shows the geographic impact of David Isla‐Ortiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Isla‐Ortiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Isla‐Ortiz more than expected).

Fields of papers citing papers by David Isla‐Ortiz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Isla‐Ortiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Isla‐Ortiz. The network helps show where David Isla‐Ortiz may publish in the future.

Co-authorship network of co-authors of David Isla‐Ortiz

This figure shows the co-authorship network connecting the top 25 collaborators of David Isla‐Ortiz. A scholar is included among the top collaborators of David Isla‐Ortiz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Isla‐Ortiz. David Isla‐Ortiz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Unger‐Saldaña, Karla, et al.. (2023). Time intervals to care and health service use experiences of uninsured cancer patients treated under public financing in Mexico City. Cancer Epidemiology. 84. 102366–102366. 4 indexed citations
2.
Fragoso‐Ontiveros, Verónica, et al.. (2023). A Pathogenic Variant Reclassified to the Pseudogene PMS2P1 in a Patient with Suspected Hereditary Cancer. International Journal of Molecular Sciences. 24(2). 1398–1398. 1 indexed citations
3.
Salcedo‐Hernández, Rosa A., et al.. (2023). Factors associated with emergency room readmission after elective surgery for ovarian carcinoma. BMC Women s Health. 23(1). 473–473.
4.
Allende‐Pérez, Silvia, et al.. (2023). Role of palliative care intervention in patients with vulvar cancer: a retrospective study. BMJ Supportive & Palliative Care. 14(e3). e2492–e2494.
5.
Cruz-Valdéz, Aurelio, Lina Sofia Palacio-Mejía, Amado D. Quezada‐Sánchez, et al.. (2023). Cervical cancer prevention program in Mexico disrupted due to COVID-19 pandemic: Challenges and opportunities. Frontiers in Oncology. 13. 1008560–1008560. 6 indexed citations
6.
Isla‐Ortiz, David, et al.. (2023). Insurance status and access to cervical cancer treatment in a specialized cancer center in Mexico. Medicine. 102(17). e33655–e33655. 1 indexed citations
7.
León, David Cantú de, Aarón González-Enciso, David Isla‐Ortiz, et al.. (2020). What is the impact of radical hysterectomy on endometrial cancer with cervical involvement?. World Journal of Surgical Oncology. 18(1). 101–101. 6 indexed citations
8.
Allende‐Pérez, Silvia, et al.. (2020). Snapshot of symptoms of advanced cervical cancer patients referred to the palliative care service in a cancer center in Mexico. International Journal of Gynecology & Obstetrics. 153(2). 335–339. 2 indexed citations
9.
Isla‐Ortiz, David, et al.. (2020). Cervical Cancer in Young Women: Do They Have a Worse Prognosis? A Retrospective Cohort Analysis in a Population of Mexico. The Oncologist. 25(9). e1363–e1371. 16 indexed citations
10.
Castro-Eguiluz, Denisse, et al.. (2019). Deterioration of nutritional status of patients with locally advanced cervical cancer during treatment with concomitant chemoradiotherapy. Journal of Human Nutrition and Dietetics. 32(4). 480–491. 28 indexed citations
11.
Gallardo‐Rincón, Dolores, et al.. (2019). Experiencia con el uso de olaparib en pacientes con cáncer de ovario. Gaceta Médica de México. 155(6). 585–589. 1 indexed citations
12.
Isla‐Ortiz, David, et al.. (2018). Prognostic factors associated with uterine sarcomas: the experience of a single institution. Journal of Obstetrics and Gynaecology. 39(2). 231–236. 3 indexed citations
13.
Pedroza‐Torres, Abraham, David Isla‐Ortiz, Luis A. Herrera, et al.. (2017). Gene signature based on degradome-related genes can predict distal metastasis in cervical cancer patients. Tumor Biology. 39(6). 3726132789–3726132789. 22 indexed citations
14.
León, David Cantú de, David Isla‐Ortiz, Luis A. Herrera, et al.. (2017). Histology as Prognostic Factor in Early-Stage Cervical Carcinoma. Experience in a Third-Level Institution. Revista de investigaci�n Cl�nica. 69(5). 286–292. 4 indexed citations
15.
16.
17.
Herrera‐Gómez, Ángel, et al.. (2016). Mujer con seminoma puro y neoplasia intratubular germinal contralateral. Informe de un caso. Cirugía y Cirujanos. 85(3). 245–249.
18.
Salcedo‐Hernández, Rosa A., Leonardo S. Lino‐Silva, David Isla‐Ortiz, et al.. (2016). Satellitosis and CD117 immunohistochemical expression correlates with poor outcome in thick vulvar melanoma. Italian Journal of Dermatology and Venereology. 152(1). 8–12. 2 indexed citations
19.
Isla‐Ortiz, David, et al.. (2016). Exenteración pélvica anterior laparoscópica en un paciente con melanoma localmente avanzado. Cirugía y Cirujanos. 85. 93–98. 1 indexed citations
20.
Chanona-Vilchis, José, et al.. (2014). [Primary ovarian carcinosarcoma. Report of eight cases].. PubMed. 82(7). 483–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ovidiu Coza Breakdown of academic impact, for papers by Nadia Raban Breakdown of academic impact, for papers by Zhongqiu Lin Breakdown of academic impact, for papers by Nisreen Anfinan Breakdown of academic impact, for papers by M.I. Castillejo Breakdown of academic impact, for papers by Lisa Richters Breakdown of academic impact, for papers by Isabell Ge Breakdown of academic impact, for papers by Alexandra Meuter Breakdown of academic impact, for papers by Sanya Anand Breakdown of academic impact, for papers by Marie Ange Mouret‐Reynier
Rankless by CCL
2026